Per Kogner

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. pmc The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
    Anna Djos
    Department of Clinical Genetics, Institute of Biomedicine, University of Gothenburg, Sahlgrenska University Hospital, SE 413 45, Gothenburg, Sweden
    Mol Cancer 11:40. 2012
  2. pmc Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas
    Susanne Fransson
    Department of Medical and Clinical Genetics, Sahlgrenska Cancer Center, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, SE 405 30, Gothenburg, Sweden
    J Mol Signal 8:4. 2013
  3. pmc Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas
    Nimrod B Kiss
    Departments of Molecular Medicine and Surgery, Stockholm, Sweden
    BMC Med Genet 13:83. 2012
  4. pmc Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation
    Cihan Cetinkaya
    Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala SE 751 85, Sweden
    BMC Cancer 13:231. 2013
  5. pmc A 6-gene signature identifies four molecular subgroups of neuroblastoma
    Frida Abel
    Department of Clinical Genetics, Gothenburg University, Gothenburg, Sweden
    Cancer Cell Int 11:9. 2011
  6. pmc Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
    Hanna Kryh
    Department of Clinical Genetics, The Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, SE 41345 Gothenburg, Sweden
    BMC Genomics 12:443. 2011
  7. pmc High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene
    Helena Caren
    Department of Clinical Genetics, Institute of Biomedicine, Goteborg University, Sahlgrenska University Hospital, SE 41345 Goteborg, Sweden
    BMC Genomics 9:353. 2008
  8. pmc Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
    Helena Caren
    Department of Clinical Genetics, Institute of Biomedicine, University of Gothenburg, Sahlgrenska University Hospital, SE 41345 Gothenburg, Sweden
    BMC Cancer 11:66. 2011

Detail Information

Publications9

  1. pmc The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
    Anna Djos
    Department of Clinical Genetics, Institute of Biomedicine, University of Gothenburg, Sahlgrenska University Hospital, SE 413 45, Gothenburg, Sweden
    Mol Cancer 11:40. 2012
    ..Data from our previously performed genome-wide DNA methylation array analysis indicated that other members of the RASSF gene family are targeted by DNA methylation in neuroblastoma...
  2. pmc Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas
    Susanne Fransson
    Department of Medical and Clinical Genetics, Sahlgrenska Cancer Center, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, SE 405 30, Gothenburg, Sweden
    J Mol Signal 8:4. 2013
    ....
  3. pmc Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas
    Nimrod B Kiss
    Departments of Molecular Medicine and Surgery, Stockholm, Sweden
    BMC Med Genet 13:83. 2012
    ..A subset of these TSGs is associated with a CpG island methylator phenotype (CIMP) in other tumor types...
  4. pmc Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation
    Cihan Cetinkaya
    Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala SE 751 85, Sweden
    BMC Cancer 13:231. 2013
    ..The purpose of the present work was to characterize the genetic and clinical diversity of such tumors by high resolution arrayCGH profiling...
  5. pmc A 6-gene signature identifies four molecular subgroups of neuroblastoma
    Frida Abel
    Department of Clinical Genetics, Gothenburg University, Gothenburg, Sweden
    Cancer Cell Int 11:9. 2011
    ..abstract:..
  6. pmc Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
    Hanna Kryh
    Department of Clinical Genetics, The Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, SE 41345 Gothenburg, Sweden
    BMC Genomics 12:443. 2011
    ..These alterations is sometimes seen in tumors as a way to inactivate a tumor suppressor gene and have been found to be important in several types of cancer...
  7. pmc High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene
    Helena Caren
    Department of Clinical Genetics, Institute of Biomedicine, Goteborg University, Sahlgrenska University Hospital, SE 41345 Goteborg, Sweden
    BMC Genomics 9:353. 2008
    ..We have used array-based copy number analysis using oligonucleotide single nucleotide polymorphisms (SNP) arrays to analyze the chromosomal structure of a large number of neuroblastoma tumors of different clinical and biological subsets...
  8. pmc Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
    Helena Caren
    Department of Clinical Genetics, Institute of Biomedicine, University of Gothenburg, Sahlgrenska University Hospital, SE 41345 Gothenburg, Sweden
    BMC Cancer 11:66. 2011
    ..Epigenetic mechanisms such as DNA methylation and histone modifications are important regulators of gene expression and are frequently involved in silencing tumor suppressor genes...